Page last updated: 2024-09-04

levofloxacin and B cepacia Infection

levofloxacin has been researched along with B cepacia Infection in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	3 (50.00)	2.80

Authors

Authors	Studies
Chang, TH; Chuang, YC; Sheng, WH; Wang, JT	1
Griffith, DC; Sabet, M	1
Barion, U; Brescia, G; Munari, S; Zanotti, C	1
Hanssens, L; Sputael, V; Van Schandevyl, G	1
Albrecht, MT; Dreier, TM; Houchens, CR; Larsen, JC; Smith, AP; Stundick, MV	1
Matoba, AY	1

Reviews

1 review(s) available for levofloxacin and B cepacia Infection

Article	Year
Animal models for Francisella tularensis and Burkholderia species: scientific and regulatory gaps toward approval of antibiotics under the FDA Animal Rule. Veterinary pathology, 2013, Volume: 50, Issue:5 Topics: Animals; Anti-Bacterial Agents; Burkholderia; Burkholderia Infections; Ciprofloxacin; Disease Models, Animal; Drug Approval; Francisella tularensis; Government Regulation; Levofloxacin; Tularemia; United States; United States Food and Drug Administration	2013

Article

Year

Animal models for Francisella tularensis and Burkholderia species: scientific and regulatory gaps toward approval of antibiotics under the FDA Animal Rule.

Veterinary pathology, 2013, Volume: 50, Issue:5

Topics: Animals; Anti-Bacterial Agents; Burkholderia; Burkholderia Infections; Ciprofloxacin; Disease Models, Animal; Drug Approval; Francisella tularensis; Government Regulation; Levofloxacin; Tularemia; United States; United States Food and Drug Administration

2013

Other Studies

5 other study(ies) available for levofloxacin and B cepacia Infection

Article	Year
Clinical characteristics and outcomes of non-cystic fibrosis patients with Burkholderia cepacia complex bacteremia at a medical center in Taiwan. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2022, Volume: 55, Issue:6 Pt 2 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Fibrosis; Hospitals; Humans; Levofloxacin; Retrospective Studies; Taiwan; Trimethoprim	2022
Activity of Aerosolized Levofloxacin against Burkholderia cepacia in a Mouse Model of Chronic Lung Infection. Antimicrobial agents and chemotherapy, 2020, 01-27, Volume: 64, Issue:2 Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Chronic Disease; Cystic Fibrosis; Female; Humans; Levofloxacin; Lung; Mice; Mice, Inbred BALB C; Respiratory Tract Infections	2020
Burkholderia gladioli sinonasal infection. European annals of otorhinolaryngology, head and neck diseases, 2019, Volume: 136, Issue:1 Topics: Anti-Bacterial Agents; Burkholderia gladioli; Burkholderia Infections; Endoscopy; Female; Humans; Immunocompetence; Levofloxacin; Maxillary Sinusitis; Middle Aged; Rhinitis; Staphylococcal Infections; Travel-Related Illness	2019
A case report of successful eradication of new isolates of Acta clinica Belgica, 2020, Volume: 75, Issue:6 Topics: Administration, Inhalation; Administration, Oral; Anti-Bacterial Agents; Burkholderia cenocepacia; Burkholderia Infections; Child, Preschool; Cystic Fibrosis; Humans; Levofloxacin; Male; Maxillary Sinus; Maxillary Sinusitis; Meropenem; Nasal Lavage; Otorhinolaryngologic Surgical Procedures; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination	2020
Polymicrobial keratitis secondary to Burkholderia ambifaria, enterococcus, and staphylococcus aureus in a patient with herpetic stromal keratitis. American journal of ophthalmology, 2003, Volume: 136, Issue:4 Topics: Amikacin; Burkholderia; Burkholderia Infections; Corneal Stroma; Drug Therapy, Combination; Enterococcus; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Keratitis, Herpetic; Levofloxacin; Male; Middle Aged; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2003